EdgarLookup

SELECTIS HEALTH, INC. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that SELECTIS HEALTH, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2019 Sep 30, 2019 $1.99M Nov 18, 2019
Q2 2019 Jun 30, 2019 $1.61M Aug 19, 2019
Q1 2019 Mar 31, 2019 $1.28M May 20, 2019
Q3 2019 Sep 30, 2018 $885.0K Nov 18, 2019
Q2 2019 Jun 30, 2018 $902.1K Aug 19, 2019
Q1 2019 Mar 31, 2018 $812.1K May 20, 2019
Q1 2014 Sep 30, 2013 $140.0K Dec 31, 2013
Q3 2013 Mar 31, 2013 $1.18M May 20, 2013
Q2 2013 Dec 31, 2012 $1.17M Feb 19, 2013
Q1 2013 Sep 30, 2012 $1.31M Nov 14, 2012
Q3 2013 Mar 31, 2012 $1.27M May 20, 2013
Q2 2013 Dec 31, 2011 $1.22M Feb 19, 2013
Q1 2013 Sep 30, 2011 $1.32M Nov 14, 2012
Q3 2011 Mar 31, 2011 $1.33M Feb 19, 2013
Q2 2011 Dec 31, 2010 $1.33M Feb 19, 2013
Q1 2012 Sep 30, 2010 $1.45M Nov 18, 2011

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $10.84M Nov 14, 2025
Q2 2025 Jun 30, 2025 $10.44M Aug 14, 2025
Q1 2025 Mar 31, 2025 $10.49M May 21, 2025
Q3 2025 Sep 30, 2024 $10.02M Nov 14, 2025
Q2 2025 Jun 30, 2024 $9.58M Aug 14, 2025
Q1 2025 Mar 31, 2024 $9.49M May 21, 2025
Q3 2024 Sep 30, 2023 $9.05M Nov 14, 2024
Q2 2024 Jun 30, 2023 $8.93M Aug 16, 2024
Q1 2024 Mar 31, 2023 $9.61M May 15, 2024
Q3 2023 Sep 30, 2022 $9.58M Nov 13, 2023
Q2 2023 Jun 30, 2022 $11.47M Sep 21, 2023
Q1 2023 Mar 31, 2022 $10.09M Aug 8, 2023
Q3 2022 Sep 30, 2021 $7.32M Jan 6, 2023
Q2 2022 Jun 30, 2021 $6.01M Sep 19, 2022
Q1 2022 Mar 31, 2021 $5.76M Sep 19, 2022
Q3 2021 Sep 30, 2020 $6.32M Nov 15, 2021
Q2 2021 Jun 30, 2020 $5.13M Aug 16, 2021
Q1 2021 Mar 31, 2020 $3.85M May 20, 2021
Q3 2020 Sep 30, 2019 $1.99M Dec 31, 2020
Q2 2020 Jun 30, 2019 $1.61M Nov 18, 2020

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $752.4K Nov 14, 2025
Q2 2025 Jun 30, 2025 ($308.0K) Aug 14, 2025
Q1 2025 Mar 31, 2025 ($656.0K) May 21, 2025
Q3 2025 Sep 30, 2024 ($1.61M) Nov 14, 2025
Q2 2025 Jun 30, 2024 $794.3K Aug 14, 2025
Q1 2025 Mar 31, 2024 ($1.03M) May 21, 2025
Q3 2024 Sep 30, 2023 ($2.26M) Nov 14, 2024
Q2 2024 Jun 30, 2023 ($2.10M) Aug 16, 2024
Q3 2023 Jun 30, 2023 ($2.10M) Nov 13, 2023
Q2 2023 Mar 31, 2023 $4.03M Sep 21, 2023
Q1 2024 Mar 31, 2023 $4.03M May 15, 2024
Q3 2023 Mar 31, 2023 $4.03M Nov 13, 2023
Q3 2023 Sep 30, 2022 ($990.9K) Nov 13, 2023
Q3 2023 Jun 30, 2022 $750.2K Nov 13, 2023
Q2 2023 Jun 30, 2022 $1.03M Sep 21, 2023
Q1 2023 Mar 31, 2022 $228.7K Aug 8, 2023
Q2 2023 Mar 31, 2022 $228.7K Sep 21, 2023
Q3 2023 Mar 31, 2022 $37.1K Nov 13, 2023
Q3 2022 Sep 30, 2021 ($53.0K) Jan 6, 2023
Q2 2022 Jun 30, 2021 ($678.8K) Sep 19, 2022

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($297.0K) Nov 14, 2025
Q2 2025 Jun 30, 2025 ($450.3K) Aug 14, 2025
Q1 2025 Mar 31, 2025 ($421.7K) May 21, 2025
Q3 2025 Sep 30, 2024 ($1.17M) Nov 14, 2025
Q2 2025 Jun 30, 2024 ($763.9K) Aug 14, 2025
Q1 2025 Mar 31, 2024 ($696.3K) May 21, 2025
Q3 2024 Sep 30, 2023 ($2.41M) Nov 14, 2024
Q2 2024 Jun 30, 2023 ($1.58M) Aug 16, 2024
Q1 2024 Mar 31, 2023 ($1.97M) May 15, 2024
Q3 2023 Sep 30, 2022 ($322.3K) Nov 13, 2023
Q2 2023 Jun 30, 2022 $1.32M Sep 21, 2023
Q1 2023 Mar 31, 2022 $615.9K Aug 8, 2023
Q3 2022 Sep 30, 2021 $736.7K Jan 6, 2023
Q2 2022 Jun 30, 2021 $2.1K Sep 19, 2022
Q1 2022 Mar 31, 2021 ($305.4K) Sep 19, 2022
Q3 2021 Sep 30, 2020 $987.0K Nov 15, 2021
Q2 2021 Jun 30, 2020 $1.65M Aug 16, 2021
Q1 2021 Mar 31, 2020 $568.1K May 20, 2021
Q3 2020 Sep 30, 2019 $634.3K Dec 31, 2020
Q2 2020 Jun 30, 2019 $370.3K Nov 18, 2020